New York S 7753: Relates to the classification of the drug xylazine as a controlled substance, and to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine

Status: REFERRED TO HEALTH (as of 2024-01-03)

State: New York · Session: 2023-2024 · Bill: S 7753

Sponsors: Mario Mattera, Jessica Scarcella-Spanton

View New York S 7753 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.